研究单位：[1]Sun Yat-sen University[2]Sun Yat-sen Univrsity Cancer Center Guangzhou,Guangdong,China,510060[3]Guangdong Provincial Hospital of Traditional Chinese Medicine Guangzhou,Guangdong,China,510120[4]Shaihai Chest Hospital Shanghai,Shanghai,China,20030
研究目的：
We hypothesized that TGR could serve as an early predictor of outcomes for aNSCLC patients undergoing immune checkpoint inhibitors (ICIs). A retrospective analysis was conducted to investigate the association of TGR with response and long-term survival of aNSCLC patients undergoing ICI therapy.
